Parsvnath Developers Share Price
3.03-0.06 (-1.94%)
-82.16% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
Share Price Live Stats
No results found
Share Market Cap & Key Ratios Overview
No results found
About
No results found
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
No results found
Parsvnath Developers Share Price
3.03-0.06 (-1.94%)
-82.16% past 1 Year
Financial overview
Peer Comparison
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Cash Flow
Consolidated
Standalone
₹
%
Fundamental Ratios
Consolidated
Standalone
Parsvnath Developers Share Price
3.03-0.06 (-1.94%)
-82.16% past 1 Year
Technical meters
No results found
Pivot
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Parsvnath Developers Share Price
3.03-0.06 (-1.94%)
-82.16% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
No results found
Bulk & block deals
No results found
Insider trading & SAST
No results found
Parsvnath Developers Share Price
3.03-0.06 (-1.94%)
-82.16% past 1 Year
Corporate Actions
Date
Type
Details
Company details
Parsvnath Developers Share Price
3.03-0.06 (-1.94%)
-82.16% past 1 Year
Corporate filings & documents
No corporate filings & documents found
Parsvnath Developers Share Price
3.03-0.06 (-1.94%)
-82.16% past 1 Year
News
Aurobindo Expects FY28 Growth From Lannett China And Biosimilars
Equity
AUROPHARMA
Aurobindo Targets Higher Peng Production By FY28 Amid Anti Dumping Filing
Equity
AUROPHARMA
Aurobindo China Facility Expected To Break Even By Third Quarter FY2027
Equity
AUROPHARMA
Brigade Enterprises Partners With IFC For Middle Income Housing Projects
Equity
BRIGADE
Government Proposes Immediate Suspension Of Drug Manufacturing Licences
Equity
SUNPHARMA
Alembic Pharmaceuticals Receives USFDA Final Approval For Olopatadine Ophthalmic Solution
Equity
APLLTD
SVLL Reports Stronger Second Quarter EBITDA And Improved Operating Margin
Equity
SVLL
SVLL Reports Strong Second Quarter Revenue Growth Of 43.21 Percent
Equity
SVLL
Cabinet Approves Rs 14,500 Crore Energy Storage Support Scheme
Broader Market
SVLL Reports Strong Second Quarter Consolidated Profit Growth
Equity
SVLL
Cummins India Q2 EBITDA Declines Sharply, Margin Contracts Year on Year
Equity
CUMMINSIND
Cummins India Reports Q2 Revenue Growth To Rs 3240 Crores
Equity
CUMMINSIND
Cummins India Q2 Profit Misses Estimates Amid Revenue And Margin Pressure
Equity
CUMMINSIND
Government Considers Incentives To Boost Domestic Battery Component Manufacturing Capacity
Equity
HSCL
Adani Kutch Copper Targets 85 Percent Capacity Utilisation By March
Equity
ADANIENT
Government Eases GPU Bidder Norms Amid Persistent Industry Viability Concerns
Broader Market
India Ten Year Benchmark Bond Yield Falls From Previous Close
Currency
Rupee Opens At Two Week High As Crude Oil Prices Slump
Currency
India Targets Rs 3 Lakh Crore Defence Production By 2029
Broader Market
India Retains Dairy And Genetically Modified Product Exclusions In Trade Agreements
Broader Market